A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Human Molecular Genetics

• Publication date

  2010-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddq179PMID 20442137PMCID PMC2893810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.

  2010cited by this paper
• Ca2+‐dependent induction of TRPM2 currents in hippocampal neurons

  2009cited by this paper
• Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1

  2009cited by this paper
• DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.

  2009cited by this paper
• A new mouse model for the trisomy of the Abcg1–U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome

  2009influential reference
• Down syndrome—recent progress and future prospects

  2009cited by this paper
• Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test

  2008cited by this paper
• Measurements of neuromuscular tone and strength in Down's syndrome children.

  2008cited by this paper
• Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults.

  2008cited by this paper
• Trisomy represses ApcMin-mediated tumours in mouse models of Down’s syndrome

  2008cited by this paper
• Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities.

  2007influential reference
• Oxidative stress induced by intense and exhaustive exercise impairs murine cognitive function.

  2007cited by this paper
• Epidemiology of Down syndrome.

  2007cited by this paper
• Down syndrome mouse models are looking up.

  2006cited by this paper
• Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

  2006cited by this paper
• Down syndrome with congenital hydrocephalus: case report.

  2006cited by this paper
• Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.

  2006cited by this paper
• NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21

  2006cited by this paper
• DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects.

  2006cited by this paper
• BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice 2

  2006cited by this paper
• Neuronal differentiation of NTE-deficient embryonic stem cells.

  2005cited by this paper
• Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12.

  2005cited by this paper
• History of genetic disease: Down syndrome and genetics — a case of linked histories

  2005cited by this paper
• Effects of the rd1 Mutation and Host Strain on Hippocampal Learning in Mice

  2005cited by this paper
• An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes

  2005cited by this paper
• Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.

  2005cited by this paper
• Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouseChromosome 12

  2005cited by this paper
• Male pachytene pairing in single and double translocation heterozygotes and spermatogenic impairment in the mouse

  2004cited by this paper
• APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.

  2004cited by this paper
• Long-term potentiation and memory.

  2004cited by this paper
• Chromosome 21 and Down syndrome: from genomics to pathophysiology

  2004cited by this paper
• Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

  2004cited by this paper
• Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome

  2004cited by this paper
• Mutagenic Insertion and Chromosome Engineering Resource (MICER)

  2004cited by this paper
• App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome

  2003cited by this paper
• Survey of embryonic stem cell line source strains in the water maze reveals superior reversal learning of 129S6/SvEvTac mice.

  2003cited by this paper
• The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

  2003cited by this paper
• Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice.

  2002cited by this paper
• Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections

  2002cited by this paper
• Contextual and cued fear conditioning in C57BL/6J and DBA/2J mice: context discrimination and the effects of retention interval.

  2002cited by this paper
• Evolutionary breakpoints on human chromosome 21.

  2001cited by this paper
• Chromosome 21: from sequence to applications.

  2001cited by this paper
• Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion

  2001cited by this paper
• The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function.

  2001cited by this paper
• S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.

  2001cited by this paper
• The use of behavioral test batteries: effects of training history.

  2001cited by this paper
• Animal Cytogenetics and Comparative Mapping

  2001cited by this paper
• Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome.

  2001cited by this paper
• Behavioral phenotype of individuals with Down syndrome.

  2000cited by this paper
• Genetic Dissection of Region Associated with Behavioral Abnormalities in Mouse Models for Down Syndrome

  2000cited by this paper
• Synaptic plasticity and memory: an evaluation of the hypothesis.

  2000influential reference
• A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice.

  1999cited by this paper
• Long-term potentiation--a decade of progress?

  1999cited by this paper
• Down syndrome in cognitive neuroscience perspective

  1999cited by this paper
• Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11.

  1998cited by this paper
• Anomalies in Down syndrome individuals in a large population-based registry.

  1998influential reference
• Thirteen years of manipulating the mouse genome: a personal history.

  1998cited by this paper
• Mildly impaired water maze performance in male Fmr1 knockout mice.

  1997cited by this paper
• Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP

  1997cited by this paper
• Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.

  1997cited by this paper
• Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells.

  1997cited by this paper
• The neuropsychology of mental retardation

  1996cited by this paper
• Long-term depression in hippocampus.

  1996cited by this paper
• Enhanced LTP in mice deficient in the AMPA receptor GluR2.

  1996cited by this paper
• A mouse model for Down syndrome exhibits learning and behaviour deficits

  1995cited by this paper
• Chromosome engineering in mice

  1995cited by this paper
• A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.

  1995cited by this paper
• Strength deficit of knee extensor muscles of individuals with Down syndrome from childhood to adolescence.

  1994cited by this paper
• Hippocampus, theta, and spatial memory.

  1993cited by this paper
• Down Syndrome in Neurobiological Perspective: An Emphasis on Spatial Cognition

  1993cited by this paper
• A synaptic model of memory: long-term potentiation in the hippocampus

  1993cited by this paper
• Gene targeting in embryonic stem cells.

  1993cited by this paper
• Isokinetic arm and leg strength of adults with Down syndrome: a comparative study.

  1992cited by this paper
• Gene targeting in embryonic stem cells.

  1991cited by this paper
• The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome.

  1989cited by this paper
• Production and analysis of chimeric mice

  1987cited by this paper
• Teratocarcinomas and embryonic stem cells : a practical approach

  1987cited by this paper
• Long-term potentiation and memory.

  1987influential reference
• A reciprocal autosomal translocation which causes male sterility in the mouse also impairs oogenesis.

  1985cited by this paper
• Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome

  1985cited by this paper
• Chromosomal abnormality rates at amniocentesis and in live-born infants.

  1983cited by this paper
• Down's syndrome with hydrocephalus treated by compressive head binding.

  1977cited by this paper
• Hydrocephalus in Down's syndrome.

  1976cited by this paper
• [Apropos of a case of combined mongolism and hydrocephalus. Discussion of the etiological factor].

  1961cited by this paper

• Gene dosage imbalance disrupts systemic metabolism in the Dp16 Down syndrome mouse model

  2026cites this paper
• Transcriptome analyses reveal the fertility defect in the Dp(16)1Yey/+ mouse model of Down syndrome

  2025cites this paper
• Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review

  2025cites this paper
• Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome

  2025cites this paper
• Brain metabolic and behavioral alterations in a Down syndrome model.

  2025cites this paper
• Hyperactivation of RAB5 disrupts the endosomal Rab cascade leading to endolysosomal dysregulation in Down syndrome: A necessary role for increased APP gene dose

  2025cites this paper
• Neonatal Obstructive Sleep Apneas in a Mouse Model of Down Syndrome.

  2025cites this paper
• Oxidative stress biomarkers as novel screening tools for trisomy 21: a case-control study

  2025cites this paper
• Ripply3 overdosage induces mid-face shortening through Tbx1 downregulation in Down syndrome models

  2024cites this paper
• Genetic interactions and co-operating effects of non-HSA21 genes on the phenotypic variability in down syndrome

  2024cites this paper
• Piezo1 regulates meningeal lymphatic vessel drainage and alleviates excessive CSF accumulation

  2024cites this paper
• In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline

  2024cites this paper
• EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model.

  2024cites this paper
• Patterns of Aneuploidy and Signaling Consequences in Cancer

  2024cites this paper
• A novel deep learning-based method for automatic stereology of microglia cells from low magnification images.

  2024cites this paper
• Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer

  2024cites this paper
• Heterogeneous subpopulations of GABAAR-responding neurons coexist across neuronal network scales and developmental stages in health and disease

  2024cites this paper
• Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation

  2024cites this paper
• Astroglial activation is exacerbated in a Down syndrome mouse model.

  2024cites this paper
• Dissecting the contribution of human chromosome 21 syntenic regions to recognition memory processes in adult and aged mouse models of Down syndrome

  2024cites this paper
• Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine β-synthase, H2S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy

  2024influential citation
• Integrative multi-omic analysis reveals conserved cell-projection deficits in human Down syndrome brains.

  2024cites this paper
• The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes

  2023cites this paper
• Cognitive impairments in a Down syndrome model with abnormal hippocampal and prefrontal dynamics and cytoarchitecture

  2023cites this paper
• Lung and Heart Biology of the Dp16 Mouse Model of down Syndrome: Implications for Studying Cardiopulmonary Disease

  2023cites this paper
• Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of down syndrome carrying human chromosome 21.

  2023cites this paper
• Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling

  2023cites this paper
• Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of APP Dose and Preclinical Studies of a γ‐Secretase Modulator

  2023cites this paper
• Transcriptomic profiling of Dip2a in the neural differentiation of mouse embryonic stem cells

  2023cites this paper
• Perspectives on pain in Down syndrome

  2023cites this paper
• Trisomy 21 induces pericentrosomal crowding delaying primary ciliogenesis and mouse cerebellar development

  2023cites this paper
• Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation

  2023influential citation
• Spermatogonial depletion and a spermatogenesis defect in the Dp(16)1Yey mouse model of Down syndrome.

  2023cites this paper
• Heterogeneous subpopulations of GABAAR-responding neurons coexist in physiological and pathological mature neuronal networks at increasing scales of complexity

  2023cites this paper
• Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease

  2023cites this paper
• A transchromosomic rat model with human chromosome 21 shows robust Down syndrome features.

  2022cites this paper
• Dysregulated systemic metabolism in a Down syndrome mouse model

  2022cites this paper
• A Mouse Model with Complete Penetrance for Atrioventricular Septal Defect/Complete AV Canal

  2022cites this paper
• Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches

  2022cites this paper
• Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose

  2022cites this paper
• Genetic mapping of APP and amyloid-β biology modulation by trisomy 21

  2022cites this paper
• Cell models for Down syndrome-Alzheimer’s disease research

  2022cites this paper
• Aberrant astrocyte protein secretion contributes to altered neuronal development in multiple models of neurodevelopmental disorders

  2022cites this paper
• Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes

  2022cites this paper
• Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model

  2021cites this paper
• Trisomy of Human Chromosome 21 Orthologs Mapping to Mouse Chromosome 10 Cause Age and Sex-Specific Learning Differences: Relevance to Down Syndrome

  2021cites this paper
• Trisomy 21 induces pericentrosomal crowding disrupting early stages of primary ciliogenesis and mouse cerebellar development

  2021cites this paper
• Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport

  2021cites this paper
• Context Fear Conditioning in Down Syndrome Mouse Models: Effects of Trisomic Gene Content, Age, Sex and Genetic Background

  2021cites this paper
• The first transchromosomic rat model with human chromosome 21 shows robust Down syndrome features

  2021cites this paper
• Coat Color-Facilitated Efficient Generation and Analysis of a Mouse Model of Down Syndrome Triplicated for All Human Chromosome 21 Orthologous Regions

  2021cites this paper
• Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes

  2021cites this paper
• From the lab to the people: major challenges in the biological treatment of Down syndrome

  2021cites this paper
• Distinct Basal Metabolism in Three Mouse Models of Neurodevelopmental Disorders

  2021cites this paper
• Time-dependent diffusion MRI probes cerebellar microstructural alterations in a mouse model of Down syndrome

  2021cites this paper
• Signalling pathways contributing to learning and memory deficits in the Ts65Dn mouse model of Down syndrome

  2021cites this paper
• Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease

  2021cites this paper
• A landmark-free morphometrics pipeline for high-resolution phenotyping: application to a mouse model of Down syndrome

  2021cites this paper
• Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome

  2021cites this paper
• Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome.

  2020cites this paper
• DIP2B Interacts With α-Tubulin to Regulate Axon Outgrowth

  2020cites this paper
• Transchromosomic technology for genomically humanized animals.

  2020cites this paper
• Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21.

  2020cites this paper
• Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome

  2020cites this paper
• Modeling Down syndrome in animals from the early stage to the 4.0 models and next.

  2020cites this paper
• Mapping behavioral landscapes in Down syndrome animal models.

  2020cites this paper
• Down syndrome: A curative prospect?

  2020cites this paper
• Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.

  2020cites this paper
• Influence of allelic differences in Down syndrome.

  2020cites this paper
• A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21

  2020cites this paper
• Behavioral Phenotyping for Down Syndrome in Mice

  2020influential citation
• Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down Syndrome

  2020cites this paper
• Down syndrome

  2020cites this paper
• Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model

  2020cites this paper
• Altered Hippocampal-Prefrontal Neural Dynamics in models of Down Syndrome

  2019cites this paper
• An Investigation on Epileptic Activity in a Transgenic Mouse Model of Down syndrome

  2019cites this paper
• In Vivo and In Vitro Genetic Models of Congenital Heart Disease.

  2019cites this paper
• Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin

  2019cites this paper
• Spatiotemporal development of spinal neuronal and glial populations in the Ts65Dn mouse model of Down syndrome

  2019cites this paper
• OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

  2019cites this paper
• Functional prediction and characterization of Dip2 gene in mice

  2019cites this paper
• Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome

  2019cites this paper
• Chr21 protein-protein interactions: enrichment in products involved in intellectual disabilities, autism and Late Onset Alzheimer Disease

  2019influential citation
• Mouse models of neurodegeneration: Know your question, know your mouse

  2019cites this paper
• Treatment with β-2 adrenergic receptoragonists: a tool for improving braindevelopmental alterations in Downsyndrome?

  2019cites this paper
• Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus

  2019cites this paper
• Genetics and genomics of Down syndrome

  2019cites this paper
• Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome

  2019cites this paper
• New approaches to studying early brain development in Down syndrome

  2019cites this paper
• A landmark-free morphometrics pipeline: Application to characterise a Down syndrome model skull phenotype

  2019cites this paper
• Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice

  2018influential citation
• Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration

  2018cites this paper
• Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras

  2018cites this paper
• Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP

  2018cites this paper
• Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.

  2018cites this paper
• Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome

  2018cites this paper
• Explorer Surveying the Down syndrome mouse model resource identifies critical regions responsible for chronic otitis media

  2018cites this paper
• Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

  2018cites this paper
• The role of DSCAM in the regulation of synaptic plasticity: possible involvement in neuropsychiatric disorders.

  2018cites this paper
• Sleep Behavior and EEG Oscillations in Aged Dp(16)1Yey/+ Mice: A Down Syndrome Model

  2018cites this paper